NCT03506529

Brief Summary

Questionnaire to be completed by patients coming for PET to identify the predictive factors of physiological hypermetabolism of the anal canal

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
644

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2018

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 24, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

September 17, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2018

Completed
Last Updated

January 11, 2019

Status Verified

January 1, 2019

Enrollment Period

2 months

First QC Date

April 12, 2018

Last Update Submit

January 10, 2019

Conditions

Keywords

TEPhypermetabolism

Outcome Measures

Primary Outcomes (4)

  • Description of predictive factors for physiological hypermetabolism of the anal canal in 18F-FDG PET / CT

    Confrontation in participants of hypermetabolism of the anal canal in PET with: number of stool/day and consistency of stool, medical history (by Answers to the specific questionnaire designed for the study)

    Only at the day of inclusion, during an appointment for a TEP exam

  • PET analysis of hypermetabolism of the anal canal

    Visual analysis of hypermetabolism of the anal canal on a 3-point scale: 0: no hypermetabolism 1. moderate hypermetabolism 2. intense hypermetabolism

    Only at the day of inclusion, during an appointment for a TEP exam

  • CT scan with measurement

    measurement of the largest rectal diameter in mm.

    Only at the day of inclusion, during an appointment for a TEP exam

  • CT scan with measurement

    Visual assessment of the rectal capacity on a 3-point scale (0, 1, 2) and content characteristics (air, feces, air and feces).

    Only at the day of inclusion, during an appointment for a TEP exam

Interventions

questionnary on predictif factors about physiological hypermetabolism of anal canal

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any patient coming for a PET

You may qualify if:

  • Patient 18 years old
  • Patient referred for 18F-FDG PET

You may not qualify if:

  • History of surgery or anal and / or perineal and / or pelvic radiotherapy, whatever the indication
  • Patient deprived of liberty, under tutorship or curatorship
  • Any associated socio-educational, medical or psychological condition that could compromise the patient's ability to participate in the study (eg illiteracy, mental retardation, etc.)
  • Pregnant woman (classic contraindication of a PET scan)
  • Opposition of the patient to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU

Caen, 14000, France

Location

Centre François Baclesse

Caen, 14076, France

Location

Related Publications (1)

  • Aide N, Tainturier LE, Nganoa C, Houdu B, Kammerer J, Galais MP, Ciappuccini R, Lasnon C. HYPHYCA: a prospective study in 613 patients conducting a comprehensive analysis for predictive factors of physiological 18F-FDG anal uptake. EJNMMI Res. 2020 Mar 20;10(1):28. doi: 10.1186/s13550-020-0615-5.

MeSH Terms

Conditions

Anus Neoplasms

Condition Hierarchy (Ancestors)

Rectal NeoplasmsColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesAnus DiseasesRectal Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2018

First Posted

April 24, 2018

Study Start

September 17, 2018

Primary Completion

November 15, 2018

Study Completion

November 15, 2018

Last Updated

January 11, 2019

Record last verified: 2019-01

Locations